Context

Abénex has successfully structured a continuation vehicle to acquire a 55% majority stake in Europa Group, facilitating a major secondary leveraged buyout and the transfer of assets from its fifth flagship fund. This strategic operation marks a pivotal shift in the group's governance, allowing the founders to trigger a structured managerial transition while retaining a significant 35% minority stake. The primary objective is to aggressively finance Europa Group's ongoing multiple build-up strategy in specialized medical media to double the group's size by 2029.

Target

Founded in 1987, Europa Group is a premier Europeanorganizer of medical conferences and professional congresses across Europe. Originally focused strictly on event management, the enterprise has successfully executed a major diversification strategy through targeted external acquisitions, expanding deeply into healthcare content, medical publishing, data marketing, and digital health communication. The company now operates two equally balanced core divisions: professional medical events and specialized healthcare media. Driven by a newly structured executive team undergoing a planned managerial transition, the group actively pursues aggressive buy-and-build strategies to continuously integrate specialized media and communication agencies, aiming to vastly multiply its operational scale in the coming years.